Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Dynavax Technologies Corporation    DVAX   US2681581029

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Income Statement Evolution
Dynavax Technologies Corpo : Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201020112012201320142015
Sales24,021,69,718,5520,686,4
Operating income (EBITDA)------
Operating profit (EBIT)-47,6-47,6-67,6-77,3-82,7-62,1
Pre-Tax Profit (EBT)--48,6-69,9---
Net income-57,3-48,6-69,9-78,0-82,0-57,2
EPS ( $)-0,69-0,39-0,41-0,41-0,38-0,04
Dividend per Share ( $)------
Yield------
Announcement Date03/08/2011
02:00pm
03/06/2012
01:00pm
03/01/2013
09:00pm
---
Finances - Leverage
Dynavax Technologies Corpo : Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201020112012201320142015
Debt------
Finance-101----
Operating income (EBITDA)------
Leverage
(Debt/EBITDA)
------
Capital Expenditure0,421,142,930,750,750,75
Book Value Per Share (BVPS)------
Cash Flow per Share------
Announcement Date03/08/2011
02:00pm
03/06/2012
01:00pm
03/01/2013
09:00pm
---
Balance Sheet Analysis
Dynavax Technologies Corpo : Balance Sheet Analysis
Assessed data source :
© 2013 Thomson Reuters
Advertisement
Financial Ratios

Size 2013e 2014e
Capitalization 459 M$ -
Company Value - 459 M$
Valuation 2013e 2014e
PER (Price / EPS)
Capitalization / Revenue 53,7x 22,3x
EV / Revenue - -
EV / EBITDA - -
Yield (DPS / Price) - -
Profitability 2013e 2014e
Operating Margin (EBIT / Sales) -904% -402%
operating laverage (Delta EBIT / Delta Sales) -1,20x -
Net Margin (Net Profit / Revenue) -912% -398%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) -63,9% -
Rate of Dividend - -
Balance Sheet Analysis 2013e 2014e
CAPEX / Sales   8,77% 3,64%
Cash Flow / Sales (Taux d'autofinancement) - -
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) - -
EPS & Dividend
Dynavax Technologies Corpo : EPS Dividend
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.